This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stock Short-Squeeze Opportunities

Mid-cap biotechnology company United Therapeutics (UTHR - Get Report) develops products for patients with infectious and chronic diseases as well as cancer.

The company has seen quarterly sales grow 30% in the last year, and shareholders have been rewarded for their faith as shares gained 66.21% over that same period. But short-sellers continue to tug at United Therapeutics' share price, pushing the company's short ratio to 11 currently.

United Therapeutics benefits from thick margins -- 12.28% as of the company's third-quarter earnings release in late October -- as well as a history of successfully commercializing drugs, something that many micro- and small-cap biotechs are often lacking.

Two catalysts could give this stock a squeeze-induced pop in the next month: a health care conference and upcoming earnings release. On Jan. 11, United Therapeutics will be present at the 28th annual JPMorgan Healthcare Conference, an event that gives the company an opportunity to showcase its therapy pipeline to analysts and institutional investors. More significant is the company's yet-unscheduled fourth-quarter 2009 earnings release, which should be coming up within the next month.
3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
DANOY $13.75 0.00%
LWAY $11.03 0.00%
RDY $46.94 0.00%
UTHR $154.26 0.00%
AAPL $117.81 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs